Literature DB >> 27813879

Ebola: Anatomy of an Epidemic.

Terrence Q Lo1, Barbara J Marston1, Benjamin A Dahl1, Kevin M De Cock1.   

Abstract

As of the end of March 2016, the West Africa epidemic of Ebola virus disease (Ebola) had resulted in a total of 28,646 cases, 11,323 of them fatal, reported to the World Health Organization. Guinea, Liberia, and Sierra Leone were most heavily affected, but Ebola cases were exported to several other African and European countries as well as the United States, with limited further transmission, including to healthcare workers. We review the descriptive epidemiology of the outbreak, novel aspects and insights concerning the unprecedented response, scientific observations, and public health implications. The large number of Ebola survivors has highlighted the frequency of persistent symptoms and the possibility of virus persistence in sanctuary sites, sometimes leading to delayed transmission. Although transmission appears to have ceased in 2016, the West Africa Ebola epidemic has profoundly influenced discussions and practice concerning global health security.

Entities:  

Keywords:  Ebolavirus Zaire; West Africa; disease outbreaks; epidemiology; global health security

Mesh:

Substances:

Year:  2016        PMID: 27813879     DOI: 10.1146/annurev-med-052915-015604

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  21 in total

1.  Geospatial clustering and correlates of deaths during the Ebola outbreak in Liberia: a Bayesian geoadditive semiparametric analysis of nationally representative cross-sectional survey data.

Authors:  Fiifi Amoako Johnson; Barbara Sakyi
Journal:  BMJ Open       Date:  2022-06-27       Impact factor: 3.006

2.  Socializing One Health: an innovative strategy to investigate social and behavioral risks of emerging viral threats.

Authors:  Christine K Johnson; Jonna A K Mazet; Karen Saylors; David J Wolking; Emily Hagan; Stephanie Martinez; Leilani Francisco; Jason Euren; Sarah H Olson; Maureen Miller; Amanda E Fine; Nga Nguyen Thi Thanh; Phuc Tran Minh; Jusuf D Kalengkongan; Tina Kusumaningrum; Alice Latinne; Joko Pamungkas; Dodi Safari; Suryo Saputro; Djeneba Bamba; Kalpy Julien Coulibaly; Mireille Dosso; Anne Laudisoit; Kouassi Manzan N'guettia Jean; Shusmita Dutta; Ariful Islam; Shahanaj Shano; Mwokozi I Mwanzalila; Ian P Trupin; Aiah Gbakima; James Bangura; Sylvester T Yondah; Dibesh Karmacharya; Rima D Shrestha; Marcelle Annie Matsida Kamta; Mohamed Moctar Mouliom Mouiche; Hilarion Moukala Ndolo; Fabien Roch Niama; Dionne Onikrotin; Peter Daszak
Journal:  One Health Outlook       Date:  2021-05-14

Review 3.  Strategy and technology to prevent hospital-acquired infections: Lessons from SARS, Ebola, and MERS in Asia and West Africa.

Authors:  Sanjeewa Jayachandra Rajakaruna; Wen-Bin Liu; Yi-Bo Ding; Guang-Wen Cao
Journal:  Mil Med Res       Date:  2017-10-27

4.  Large Outbreak of Neisseria meningitidis Serogroup C - Nigeria, December 2016-June 2017.

Authors:  Chimeremma Nnadi; John Oladejo; Sebastian Yennan; Adesola Ogunleye; Chidinma Agbai; Lawal Bakare; Mohammed Abdulaziz; Amina Mohammed; Mary Stephens; Kyadindi Sumaili; Olivier Ronveaux; Helen Maguire; Debra Karch; Mahmood Dalhat; Martin Antonio; Andre Bita; Ifeanyi Okudo; Patrick Nguku; Ryan Novak; Omotayo Bolu; Faisal Shuaib; Chikwe Ihekweazu
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-12-15       Impact factor: 17.586

5.  Inhibitors of signal peptide peptidase and subtilisin/kexin-isozyme 1 inhibit Ebola virus glycoprotein-driven cell entry by interfering with activity and cellular localization of endosomal cathepsins.

Authors:  Teresa Plegge; Martin Spiegel; Nadine Krüger; Inga Nehlmeier; Michael Winkler; Mariana González Hernández; Stefan Pöhlmann
Journal:  PLoS One       Date:  2019-04-11       Impact factor: 3.240

6.  Novel amodiaquine derivatives potently inhibit Ebola virus infection.

Authors:  Yasuteru Sakurai; Norikazu Sakakibara; Masaaki Toyama; Masanori Baba; Robert A Davey
Journal:  Antiviral Res       Date:  2018-11-03       Impact factor: 5.970

7.  Calu-3 cells are largely resistant to entry driven by filovirus glycoproteins and the entry defect can be rescued by directed expression of DC-SIGN or cathepsin L.

Authors:  Mariana González-Hernández; Andreas Müller; Thomas Hoenen; Markus Hoffmann; Stefan Pöhlmann
Journal:  Virology       Date:  2019-04-03       Impact factor: 3.616

Review 8.  Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms.

Authors:  Amy D Proal; Michael B VanElzakker
Journal:  Front Microbiol       Date:  2021-06-23       Impact factor: 5.640

Review 9.  Observed and Potential Impacts of the COVID-19 Pandemic on the Environment.

Authors:  Sorin Cheval; Cristian Mihai Adamescu; Teodoro Georgiadis; Mathew Herrnegger; Adrian Piticar; David R Legates
Journal:  Int J Environ Res Public Health       Date:  2020-06-10       Impact factor: 3.390

10.  Promoting Scientific Transparency to Facilitate the Safe and Open International Exchange of Biological Materials and Electronic Data.

Authors:  Kenneth B Yeh; Corina Monagin; Jacqueline Fletcher
Journal:  Trop Med Infect Dis       Date:  2017-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.